In another series of patients, mutation of PRSS1 did not seem to play a role in terms of pancreatic cancer development.34 It may thus be that mutations in the gene is not the essential change affecting pancreatic cancers, but rather the already present and physiological production of trypsin may be what drives cancer progression. The gene discussed is PRSS1; the disease is cancer.